RATIOS
Concord Biotech Ltd.
BSE
Jun 13
2110.55
+50.30 (+ 2.44%)
Volume
4844
Prev. Close
2060.25
Open Price
2019.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 13
2109.70
+46.10 (+ 2.23%)
Volume
166986
Prev. Close
2063.60
Open Price
2010.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
ISIN No
|
INE338H01029
|
Market Cap. ( ₹ in Cr. )
|
22070.88
|
P/BV
|
13.88
|
Book Value ( ₹ )
|
152.02
|
BSE Code
|
543960
|
52 Week High/Low ( ₹ )
|
2664/1345
|
FV/ML
|
1/1
|
P/E(X)
|
59.39
|
NSE Code
|
CONCORDBIOEQ
|
Book Closure
|
29/06/2024
|
EPS ( ₹ )
|
35.52
|
Div Yield (%)
|
0.51
|
Months | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 |
| | | |
PER SHARE RATIOS | | | |
| | | |
Basic EPS (Rs.) | 35.65 | 29.13 | 22.76 |
Diluted EPS (Rs.) | 35.65 | 29.13 | 22.76 |
Cash EPS (Rs.) | 40.85 | 34.25 | 27.93 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 173.27 | 145.80 | 123.50 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 173.27 | 145.80 | 123.50 |
Dividend / Share (Rs.) | 10.70 | 8.75 | 6.83 |
Revenue From Operations / Share (Rs.) | 114.71 | 97.21 | 81.55 |
PBDIT / Share (Rs.) | 52.65 | 44.48 | 36.19 |
PBIT / Share (Rs.) | 47.45 | 39.36 | 31.02 |
PBT / Share (Rs.) | 47.40 | 39.11 | 30.59 |
Net Profit / Share (Rs.) | 35.65 | 29.13 | 22.76 |
| | | |
PROFITABILITY RATIOS | | | |
| | | |
PBDIT Margin (%) | 45.89 | 45.75 | 44.37 |
PBIT Margin (%) | 41.36 | 40.48 | 38.04 |
PBT Margin (%) | 41.31 | 40.23 | 37.51 |
Net Profit Margin (%) | 31.07 | 29.96 | 27.91 |
Return on Networth / Equity (%) | 20.57 | 19.97 | 18.43 |
Return on Capital Employeed (%) | 26.83 | 26.44 | 24.51 |
Return On Assets (%) | 18.33 | 17.93 | 15.72 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.02 |
Asset Turnover Ratio (%) | 0.64 | 0.63 | 0.60 |
| | | |
LIQUIDITY RATIOS | | | |
| | | |
Current Ratio (X) | 6.17 | 6.30 | 3.82 |
Quick Ratio (X) | 4.87 | 4.84 | 2.70 |
Inventory Turnover Ratio (X) | 1.18 | 0.87 | 0.82 |
Dividend Payout Ratio (NP) (%) | 0.00 | 23.44 | 22.49 |
Dividend Payout Ratio (CP) (%) | 0.00 | 19.94 | 18.33 |
Earning Retention Ratio (%) | 0.00 | 76.56 | 77.51 |
Cash Earning Retention Ratio (%) | 0.00 | 80.06 | 81.67 |
| | | |
COVERAGE RATIOS | | | |
| | | |
Interest Coverage Ratio (%) | 1040.58 | 182.35 | 83.94 |
Interest Coverage Ratio (Post Tax) (%) | 705.64 | 120.41 | 53.80 |
| | | |
VALUATION RATIOS | | | |
| | | |
Enterprise Value (Cr.) | 17536.50 | 15881.24 | 0.00 |
EV / Net Operating Revenue (X) | 14.61 | 15.62 | 0.00 |
EV / EBITDA (X) | 31.84 | 34.13 | 0.00 |
MarketCap / Net Operating Revenue (X) | 14.61 | 15.66 | 0.00 |
Retention Ratios (%) | 0.00 | 76.55 | 77.50 |
Price / BV (X) | 9.67 | 10.44 | 0.00 |
Price / Net Operating Revenue (X) | 14.61 | 15.66 | 0.00 |
EarningsYield | 0.02 | 0.01 | 0.00 |